Skip to main content
. Author manuscript; available in PMC: 2021 Apr 16.
Published in final edited form as: Cell. 2020 Apr 16;181(2):236–249. doi: 10.1016/j.cell.2020.03.053

Figure 2. HTAN Is Complementary to Previous Large-Scale Cancer Genomics Initiatives and Ongoing Atlas Efforts.

Figure 2.

HTAN will illuminate aspects of malignancy that could not be fully addressed by previous large-scale cancer genomics programs and is complementary to ongoing atlas building efforts across healthy and disease tissues.